๐ Vertex Pharma $VRTX pops 6.6% at the open after Q2 earnings beat the Street
Vertex Pharmaceuticals is one of the cleanest winners off today's open, jumping 6.6% after handily beating second-quarter earnings expectations. The biotech keeps cashing in on its dominant cystic fibrosis franchise while the broader market is mixed โ indexes are flat to slightly lower with oil prices climbing on Middle East tensions. CPI is due Wednesday, PPI Thursday, so macro could shift the tape fast. Not financial advice. Is $VRTX the steady hand to hold into a potentially choppy week?